01.19.24
Skintensive—a derm-dispensed skincare brand founded by Harvard-trained dermatologists—has hired Dr. John Bartolone PhD as its new chief science officer.
The brand, best known for its Skintensive Bruise Cream and its products for maturing skin, has also acquired a specialty skincare line called ScarSmart.
Prior to pivoting to cosmetics, Dr. Bartolone was an assistant professor at the University of Connecticut, where he was awarded the “Best Paper of the Year” from the Society of Toxicology for ground-breaking research on Acetaminophen Hepatotoxicity.
“Dr. Mikailov and I are humbled and excited for John Bartolone to join us at Skintensive,” said co-founder Vladimir Ratushny M.D., Ph.D., FAAD “Not only does he provide an encyclopedic insight into the skincare industry, his experience in product development, brand positioning, and creating breakthrough innovations is truly invaluable.”
"We initially developed the Skintensive Bruise Cream to address acute and chronic bruising and solar purpura that is exceedingly common in our patients,” said Anar Mikailov, M.D., FAAD. “Those same patients also need options for the prevention and improvement of scars on their fragile skin. Now, the patients who trust our Skintensive brand will have access to an incredible product that dermatologists have recommended for many years."
The Skintensive brand is carried by dermatologist offices in the US and will be exhibit at the 2024 American Academy of Dermatology conference in San Diego in March.
The brand, best known for its Skintensive Bruise Cream and its products for maturing skin, has also acquired a specialty skincare line called ScarSmart.
Bartolone's Experience
With more than 30 years of experience leading research and development labs at Procter & Gamble and Unilever, Bartolone has launched numerous “first-of-its-kind” technologies and products in skincare and haircare. Pioneering core global science platforms, including anti-aging and skin lightening, Dr. Bartolone most recently launched Unilever’s first plant-based preservative system.Prior to pivoting to cosmetics, Dr. Bartolone was an assistant professor at the University of Connecticut, where he was awarded the “Best Paper of the Year” from the Society of Toxicology for ground-breaking research on Acetaminophen Hepatotoxicity.
“Dr. Mikailov and I are humbled and excited for John Bartolone to join us at Skintensive,” said co-founder Vladimir Ratushny M.D., Ph.D., FAAD “Not only does he provide an encyclopedic insight into the skincare industry, his experience in product development, brand positioning, and creating breakthrough innovations is truly invaluable.”
Skintensive Acquires Scar Smart
In addition to the appointment of Bartolone, Skintensive has acquired Scar Smart, a silicone-based scar revision product line that includes Scar Smart Silicone Scar Gel and Scar Smart Silicone Scar Sheets."We initially developed the Skintensive Bruise Cream to address acute and chronic bruising and solar purpura that is exceedingly common in our patients,” said Anar Mikailov, M.D., FAAD. “Those same patients also need options for the prevention and improvement of scars on their fragile skin. Now, the patients who trust our Skintensive brand will have access to an incredible product that dermatologists have recommended for many years."
The Skintensive brand is carried by dermatologist offices in the US and will be exhibit at the 2024 American Academy of Dermatology conference in San Diego in March.